| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.09. | Zhongchao announces 1-for-2 share consolidation | 2 | Seeking Alpha | ||
| 30.09. | Zhongchao Inc. Announces 1-for-2 Share Consolidation | 187 | PR Newswire | SHANGHAI, Sept. 30, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services... ► Artikel lesen | |
| ZHONGCHAO Aktie jetzt für 0€ handeln | |||||
| 11.09. | Zhongchao Inc. - 6-K, Report of foreign issuer | 15 | SEC Filings | ||
| 11.08. | Zhongchao Inc. - 6-K, Report of foreign issuer | 12 | SEC Filings | ||
| 23.07. | Morning Market Movers: 707 Cayman, Zhongchao, NVE Corporation, Medpace See Big Swings | 1.626 | AFX News | BEIJING (dpa-AFX) - At 8:25 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 22.07. | Zhongchao Inc. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 03.07. | Zhongchao Stock Surges 200% After Hours: Here's Why | 16 | Benzinga.com | ||
| 25.06. | Zhongchao announces 1-for-3 share consolidation | 1 | Seeking Alpha | ||
| 25.06. | Zhongchao kündigt Aktienzusammenlegung im Verhältnis 1:3 an | 22 | Investing.com Deutsch | ||
| 25.06. | Zhongchao announces 1-for-3 reverse stock split effective Sunday | 2 | Investing.com | ||
| 25.06. | Zhongchao Inc. Announces 1-for-3 Share Consolidation | 564 | PR Newswire | SHANGHAI, June 25, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services... ► Artikel lesen | |
| 23.06. | Zhongchao Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 05.06. | Zhongchao Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.06. | Zhongchao führt am Sonntag Reverse-Aktiensplit im Verhältnis 1:31 durch | 3 | Investing.com Deutsch | ||
| 04.06. | Zhongchao Inc. Announces 1-for-31 Share Consolidation | 291 | PR Newswire | SHANGHAI, June 4, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services... ► Artikel lesen | |
| 29.05. | Zhongchao prices $5 million public offering at $0.54 per unit | 18 | Investing.com | ||
| 29.05. | Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering | 282 | PR Newswire | SHANGHAI, May 29, 2026 /PRNewswire/ -- Zhongchao Inc. ("Zhongchao" or the "Company") (NASDAQ: ZCMD), a platform-based internet technology company offering services... ► Artikel lesen | |
| 22.05. | Zhongchao Inc. - F-1/A, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
| 07.05. | Zhongchao Inc. - F-1, Registration statement for certain foreign private issuers | - | SEC Filings | ||
| 26.02. | Zhongchao Inc. Announces 1-for-8 Share Consolidation | 271 | PR Newswire | SHANGHAI, Feb. 26, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 12,360 | +1,64 % | BRANDMELDUNG bei Eckert&Ziegler: Diese brandneue Prognose ändert einfach alles - Mein Rat: sofort handeln! | ||
| SERNOVA BIOTHERAPEUTICS | 0,070 | -4,88 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics | EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics
07.09.2026 / 09:31 CET/CEST
The... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | NuGen Medical Devices Inc.: NuGen Announces Loan Agreement with Sol-Millennium Medical HK Limited | Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce the entering into of a loan agreement (the "Loan Agreement")... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| UNIDOC HEALTH | 0,040 | -23,08 % | XFRA L7T: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,115 | +2,29 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| QUEST DIAGNOSTICS | 201,30 | -2,19 % | Dividendenbekanntmachungen (06.10.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ANGLO AMERICAN PLC ADR US03485P4090 0,115 USD EUR BANK CENTRAL ASIA TBK ADR US69368G1058 0,035 USD EUR BANK OF NOVA SCOTIA CA0641491075 1... ► Artikel lesen | |
| QUIDELORTHO | 11,435 | +3,34 % | Sanjeev Sharma wird neuer Leiter Investor Relations bei QuidelOrtho | ||
| VERU | 2,460 | +1,65 % | Veru Inc.: Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines' RASONQUE) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial | ||
| LIFEWARD | 6,360 | 0,00 % | Lifeward Ltd. - 8-K, Current Report | ||
| SENSEONICS | 7,950 | -1,24 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,760 | -1,29 % | Tempest Therapeutics beruft Nancy Freda-Smith in den Verwaltungsrat |